NO20055835L - Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20055835L NO20055835L NO20055835A NO20055835A NO20055835L NO 20055835 L NO20055835 L NO 20055835L NO 20055835 A NO20055835 A NO 20055835A NO 20055835 A NO20055835 A NO 20055835A NO 20055835 L NO20055835 L NO 20055835L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- cyclic amine
- Prior art date
Links
- -1 Cyclic amine Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0310724.0A GB0310724D0 (en) | 2003-05-09 | 2003-05-09 | Chemical compounds |
| PCT/EP2004/005005 WO2004099143A1 (en) | 2003-05-09 | 2004-05-07 | Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055835D0 NO20055835D0 (no) | 2005-12-08 |
| NO20055835L true NO20055835L (no) | 2006-02-07 |
Family
ID=9957781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055835A NO20055835L (no) | 2003-05-09 | 2005-12-08 | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070073061A1 (pt) |
| EP (1) | EP1622871A1 (pt) |
| JP (1) | JP4684221B2 (pt) |
| KR (1) | KR20060009313A (pt) |
| CN (1) | CN100534983C (pt) |
| AR (1) | AR044269A1 (pt) |
| AU (1) | AU2004235967B2 (pt) |
| BR (1) | BRPI0410154A (pt) |
| CA (1) | CA2524894A1 (pt) |
| EG (1) | EG24668A (pt) |
| GB (1) | GB0310724D0 (pt) |
| IS (1) | IS8164A (pt) |
| MA (1) | MA27795A1 (pt) |
| MX (1) | MXPA05012096A (pt) |
| MY (1) | MY140027A (pt) |
| NO (1) | NO20055835L (pt) |
| NZ (1) | NZ543068A (pt) |
| RU (1) | RU2392270C2 (pt) |
| TW (1) | TWI332499B (pt) |
| WO (1) | WO2004099143A1 (pt) |
| ZA (1) | ZA200508339B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412865D0 (en) | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
| US7844037B2 (en) | 2005-08-08 | 2010-11-30 | Palm, Inc. | Method and device for enabling message responses to incoming phone calls |
| US8067447B2 (en) | 2006-11-01 | 2011-11-29 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| MX2011001846A (es) * | 2008-09-01 | 2011-04-04 | Neurosearch As | Nuevos derivados de piperidina-4-acetamida y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina. |
| ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
| CN106187999A (zh) * | 2015-05-04 | 2016-12-07 | 复旦大学 | 取代哌啶类化合物及其制备方法和用途 |
| BR112023019211A2 (pt) | 2021-03-23 | 2023-11-28 | Bioage Labs Inc | Inibidores de inflamassoma nlrp3 |
| US11787805B2 (en) | 2022-01-28 | 2023-10-17 | BioAge Labs, Inc. | N-oxide inhibitors of NLRP3 inflammasome |
| TW202547472A (zh) | 2024-03-26 | 2025-12-16 | 美商百愛及生物醫藥公司 | Nlrp3發炎體之抑制劑 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US309720A (en) * | 1884-12-23 | William p | ||
| NL262366A (pt) * | 1960-03-14 | |||
| GB1356117A (en) * | 1970-12-16 | 1974-06-12 | Searle & Co | 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives |
| US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| DE19603767A1 (de) * | 1996-02-02 | 1997-08-07 | Hoechst Ag | Pyrrolidinpropionsäurederivate mit bradykinin-antagonistischer Wirkung |
| US6034136A (en) * | 1997-03-20 | 2000-03-07 | Novartis Ag | Certain cyclic thio substituted acylaminoacid amide derivatives |
| AU1415099A (en) * | 1997-11-18 | 1999-06-07 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
| ATE460163T1 (de) * | 2001-04-12 | 2010-03-15 | Pharmacopeia Llc | Arly und diaryl piperidinderivate verwendbar als mch-hemmer |
| AR037429A1 (es) * | 2001-11-26 | 2004-11-10 | Schering Corp | Derivados de piperidina antagonistas de la mch, composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos derivados, solos o en combinacion, para la fabricacion de un medicamento para tratamiento de la obesidad y de trastornos del snc |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| US20060128752A1 (en) * | 2002-07-03 | 2006-06-15 | Giuseppe Alvaro | Chemical compounds |
-
2003
- 2003-05-09 GB GBGB0310724.0A patent/GB0310724D0/en not_active Ceased
-
2004
- 2004-05-07 AR ARP040101565A patent/AR044269A1/es not_active Application Discontinuation
- 2004-05-07 BR BRPI0410154-5A patent/BRPI0410154A/pt not_active IP Right Cessation
- 2004-05-07 MX MXPA05012096A patent/MXPA05012096A/es active IP Right Grant
- 2004-05-07 MY MYPI20041688A patent/MY140027A/en unknown
- 2004-05-07 US US10/554,822 patent/US20070073061A1/en not_active Abandoned
- 2004-05-07 EP EP04731635A patent/EP1622871A1/en not_active Withdrawn
- 2004-05-07 CN CNB2004800194957A patent/CN100534983C/zh not_active Expired - Fee Related
- 2004-05-07 WO PCT/EP2004/005005 patent/WO2004099143A1/en not_active Ceased
- 2004-05-07 NZ NZ543068A patent/NZ543068A/xx unknown
- 2004-05-07 AU AU2004235967A patent/AU2004235967B2/en not_active Ceased
- 2004-05-07 CA CA002524894A patent/CA2524894A1/en not_active Abandoned
- 2004-05-07 RU RU2005138315/04A patent/RU2392270C2/ru not_active IP Right Cessation
- 2004-05-07 JP JP2006505412A patent/JP4684221B2/ja not_active Expired - Fee Related
- 2004-05-07 KR KR1020057021196A patent/KR20060009313A/ko not_active Abandoned
- 2004-05-07 TW TW093112840A patent/TWI332499B/zh not_active IP Right Cessation
-
2005
- 2005-10-14 ZA ZA200508339A patent/ZA200508339B/en unknown
- 2005-10-29 EG EGNA2005000691 patent/EG24668A/xx active
- 2005-11-08 MA MA28584A patent/MA27795A1/fr unknown
- 2005-12-01 IS IS8164A patent/IS8164A/is unknown
- 2005-12-08 NO NO20055835A patent/NO20055835L/no unknown
-
2007
- 2007-10-10 US US11/869,945 patent/US20090192194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090192194A1 (en) | 2009-07-30 |
| US20070073061A1 (en) | 2007-03-29 |
| RU2005138315A (ru) | 2007-06-20 |
| JP4684221B2 (ja) | 2011-05-18 |
| BRPI0410154A (pt) | 2006-05-16 |
| IS8164A (is) | 2005-12-01 |
| MA27795A1 (fr) | 2006-03-01 |
| EP1622871A1 (en) | 2006-02-08 |
| TW200510309A (en) | 2005-03-16 |
| NO20055835D0 (no) | 2005-12-08 |
| KR20060009313A (ko) | 2006-01-31 |
| MXPA05012096A (es) | 2006-02-08 |
| WO2004099143A1 (en) | 2004-11-18 |
| AU2004235967B2 (en) | 2008-10-23 |
| MY140027A (en) | 2009-11-30 |
| TWI332499B (en) | 2010-11-01 |
| RU2392270C2 (ru) | 2010-06-20 |
| EG24668A (en) | 2010-04-11 |
| AU2004235967A1 (en) | 2004-11-18 |
| AR044269A1 (es) | 2005-09-07 |
| GB0310724D0 (en) | 2003-06-11 |
| CN1819995A (zh) | 2006-08-16 |
| ZA200508339B (en) | 2006-10-25 |
| CN100534983C (zh) | 2009-09-02 |
| NZ543068A (en) | 2009-07-31 |
| JP2006525975A (ja) | 2006-11-16 |
| CA2524894A1 (en) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
| NO20052683D0 (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
| NO20042155L (no) | N-adamantylmetylderivater og mellomprodukter som farmasoytiske sammensetninger og fremgangsmater til deres fremstilling | |
| DK1523488T3 (da) | Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
| DK1322158T3 (da) | Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf | |
| NO20023643L (no) | Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem | |
| DK1558612T3 (da) | Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK2083007T3 (da) | Tiotropiumsalte, fremgangsmåder til deres fremstilling og lægemiddelformuleringer indeholdende disse | |
| NO20055835D0 (no) | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
| NO20043188L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20031219L (no) | Nye forbindelser avledet fra kinazolin, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK2067779T3 (da) | Tiotropiumsalte, fremgangsmåde til deres fremstilling og lægemiddelformuleringer indeholdende disse | |
| NO20031643L (no) | Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1742927T3 (da) | Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf | |
| NO20055167D0 (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20034614L (no) | Nye [3,4-a:3,4-c]karbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20041313L (no) | Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20035215L (no) | Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20052414L (no) | Nye pyrrolidin- og tiazolidinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| DK1150970T3 (da) | (1-phenacy-3-phenyl-3-piperidylethyl)piperidin-derivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætningner indeholdende dem | |
| NO20043910L (no) | Nye aminosyreforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |